Digital · Origem US / UK

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

Fonte: Marina Temkin · Publicado 23 de set. de 2026, 21:31

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

Em Digital, Marina Temkin coloca esta história no centro do dia: The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s. A FlexChar destaca porque concentra buscas e conversa agora.

Resumo editorial da FlexChar. A reportagem completa pertence à fonte original.

Ler na fonte original

Blog

Privacidade digital básica: 9 mudanças que importam Ferramentas digitais grátis que ainda valem em 2026 Como organizar a semana sem mais um app de produtividade Windows lento: como corrigir em 2026

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

Você também pode gostar

U.S. Intervention in the UN Security Council Meeting on "Artificial Intelligence and International Security"

Artificial Intelligence Will Not Make Us Extinct

If Amazon doesn’t know how to eliminate carbon emissions, then who does?

US diplomats told to use term ‘super intelligence’ not ‘artificial intelligence’ after Trump's call